Stay updated on Open-Label Surufatinib in EU NET Patients Clinical Trial

Sign up to get notified when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Open-Label Surufatinib in EU NET Patients Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 for the study record. This appears to be a metadata update rather than a change to the core study content.
    Difference
    0.0%
    Check dated 2026-03-20T19:57:01.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. No study data or content were changed.
    Difference
    0.0%
    Check dated 2026-03-06T18:36:45.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision updates: added v3.4.2 and removed v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T11:50:32.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T00:01:15.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Revision entry updated from v3.3.3 to v3.3.4; core study details remain unchanged.
    Difference
    0.0%
    Check dated 2026-01-15T04:41:01.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    - A consolidated Locations section was added listing study sites across Alabama, California, Georgia, New York, and Texas, with the previous state-specific location headings removed. The page revision was updated to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-24T15:16:36.000Z thumbnail image

Stay in the know with updates to Open-Label Surufatinib in EU NET Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.